ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

CANAKINUMABUM

Active substance (INN) · ATC L04AC08 · 2 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
L039M	ARTRITA IDIOPATICĂ JUVENILĂ - AGENŢI BIOLOGICI: ADALIMUMABUM1 (original și biosimilar), ETANERCEPTUM1 (original și biosimilar), ABATACEPTUM1, TOCILIZUMABUM1(origi…	In force	medicine of the protocol	C1-G31E	NO
L04AC08	CANAKINUMABUM	In force	medicine of the protocol	C1-G31I	NO

History: entries into and exits from protocols

Month	Type	Code	Protocol	Level
April 2026	Medicine added	L039M	ARTRITA IDIOPATICĂ JUVENILĂ - AGENŢI BIOLOGICI: ADALIMUMABUM1 (original și biosimilar), ETANERCEPTUM1 (original și biosimilar), ABATACEP	medicine of the protocol

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
ILARIS 150 mg	PULB. PT. SOL. INJ.	150mg	NOVARTIS EUROPHARM LIMITED - IRLANDA	L04AC08	PR
ILARIS 150 mg/ml	SOL. INJ.	150mg/ml	NOVARTIS EUROPHARM LIMITED - IRLANDA	L04AC08	PR
ILARIS 150 mg/ml	SOL. INJ. IN STILOU INJECTOR (PEN) PREUMPLUT	150mg/ml	NOVARTIS EUROPHARM LIMITED - IRLANDA	L04AC08	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.